Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

Citation
Pj. Laitinen et al., Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia, CIRCULATION, 103(4), 2001, pp. 485-490
Citations number
33
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
103
Issue
4
Year of publication
2001
Pages
485 - 490
Database
ISI
SICI code
0009-7322(20010130)103:4<485:MOTCRR>2.0.ZU;2-5
Abstract
Background-Familial polymorphic ventricular tachycardia is an autosomal-dom inant, inherited disease with a relatively early onset and a mortality rate of approximate to 30% by the age of 30 years. Phenotypically, it is charac terized by salvoes of bidirectional and polymorphic ventricular tachycardia s in response to vigorous exercise, with no structural evidence of myocardi al disease. We previously mapped the causative gene to chromosome 1q42-q43. In the present study, we demonstrate that patients with familial polymorph ic ventricular tachycardia have missense mutations in the cardiac sarcoplas mic reticulum calcium release channel (ryanodine receptor type 2 [RyR2]). Methods and Results-In 3 large families studied, 3 different RyR2 mutations (P2328S, Q4201R, V4653F) were detected and shown to fully cosegregate with the characteristic arrhythmic phenotype. These mutations were absent in th e nonaffected family members and in 100 healthy controls. In addition to id entifying 3 causative mutations, we identified a number of single nucleotid e polymorphisms that span the genomic structure of RyR2 and will be useful for candidate-based association studies for other arrhythmic disorders. Conclusions-Our data illustrate that mutations of the RyR2 gene cause at le ast one variety of inherited polymorphic tachycardia. These findings define a new entity of disorders of myocardial calcium signaling.